EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study

Sheng Li iD, Xiaoqiang Liu, Liu Weipeng, Bin Fu iD

Future Oncology · 01.12.2022 · 18 (38) · 4171-4181

DOI: 10.2217/fon-2022-0843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Oncology, online erschienen am 18.01.2023. Verfasst von Sheng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanchang, China. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangxi Provincial "Double Thousand Plan" Fund Project, Jiangxi Provincial “Double Thousand Plan” Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To develop a prognostic model to predict the overall survival of primary bladder neuroendocrine carcinoma (BNEC) patients.

Methods

Using univariate and multivariate Cox regression analyses, a nomogram was constructed. Calibration curves, receiver operating characteristic curves and C-index were utilized to evaluate the performance.

Results

The study enrolled 906 BNEC patients. The following variables were incorporated in the nomogram: age, marital status, Tumor node metastasis (TNM) stage, chemotherapy and surgery. The nomogram had a C-index of 0.702 in the training cohort and 0.724 in the validation cohort.

Conclusion

Compared with the TNM staging system, the proposed nomogram exhibits superior prognostic discrimination and survival prediction. Neuroendocrine bladder cancer accounts for

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, NeuroendocrineUrinary Bladder NeoplasmsHumansNomogramsUrinary BladderResearchMarital StatusNeoplasm StagingSEER ProgramPrognosis

Stichwörter der Autor:innen

SEERbladder neuroendocrine carcinomanomogramoverall survivalprognosis

Autor:innen und Institutionen

  • Department of Urology, Nanchang, China.
  • The First Affiliated Hospital of Nanchang University, No.17, Yongwai Zhengjie, Donghu District, Nanchang City, Jiangxi Province, 330000, China.

ORCID-Profile: Sheng Li, Bin Fu

Förderung

  • Jiangxi Provincial "Double Thousand Plan" Fund Project
  • Jiangxi Provincial “Double Thousand Plan” Fund Project

Zitieren

APA

Li, S., Liu, X., Weipeng, L., & Fu, B. (2022). Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study. Future Oncology, 18(38), 4171-4181. https://doi.org/10.2217/fon-2022-0843

Vancouver

Li S, Liu X, Weipeng L, Fu B. Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study. Future Oncology. 2022;18(38):4171-4181. doi:10.2217/fon-2022-0843

BibTeX
@article{Li2022,
  author = {Li, Sheng and Liu, Xiaoqiang and Weipeng, Liu and Fu, Bin},
  title = {Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study},
  journal = {Future Oncology},
  year = {2022},
  volume = {18},
  number = {38},
  pages = {4171--4181},
  doi = {10.2217/fon-2022-0843}
}
Kostenlos starten →